22 24-months on treatment: Open-label phase I/II long-term...

22 24-months on treatment: Open-label phase I/II long-term study of enzyme replacement therapy (ERT) with Gene-Activated® human glucocerebrosidase (GA-GCB) in patients with type I Gaucher disease

Ari Zimran, G. Altarescu, C. Fratazzi, R. Mensah, D. Elstein
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
92
Year:
2007
Language:
english
DOI:
10.1016/j.ymgme.2007.08.027
File:
PDF, 46 KB
english, 2007
Conversion to is in progress
Conversion to is failed